Clinical Trial Update: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports completed Phase 1 and Phase 2 studies evaluating alpha-lipoic acid and omega-3 fatty acids for Alzheimer's disease, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-13